Osiris Therapeutics (United States)

Osiris Therapeutics (United States)

Osiris Therapeutics, Inc. was an American company founded in March 1993 following the identification of mesenchymal stem cells by Dr. Arnold Caplan and colleagues at Case Western Reserve University in Cleveland, Ohio. Derived from Wikipedia licensed CC-BY-SA.

Open Access statistics for Osiris Therapeutics (United States), United States, covering academic research published from 2000 to 2025. Read More.


Open Access Percentage

53%


Total
Publications

186


Total Open
Publications

99


Total
Citations

37K


Open Access
Percentage

53%


Total
Publications

186


Total Open
Publications

99


Total
Citations

37K

Wikipedia

Website

download

Breakdown

28% 23% 4% 45%

Publisher Open

28%

Both

23%

Other Platform Open

4%

Closed

45%

Percentage of Open Access over time

0%10%20%30%40%50%60%70%80%90%100%
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Publisher Open

Both

Other Platform Open

Closed

Volume of Open Access over time

0246810121416182022Total Publications
20002001200220032004200520062007200820092010201120122013201420152016201720182019202020212022202320242025

Open

Closed

Publisher Open

39%OA Journal

OA Journal 39%

38

Hybrid 30%

29

No Guarantees 31%

30

Other Platform Open

Domain 61%

31

Institution 51%

26

Other Internet 12%

6

Public 6%

3

Preprint 4%

2

Other Platform Locations

Name

Platform Type

Publications

PubMed Central
Domain
31
doaj.org OAI-PMH Repository
Institution
14
Le Centre pour la Communication Scientifique Directe - HAL - Diderot
Institution
5
DOI
Other Internet
4
Unknown Repository
Other Internet
2
Figshare
Public
2
Europe PMC
Domain
2
Université Libre de Bruxelles
Institution
1
uab.pt OAI-PMH Repository
Institution
1
Royal Veterinary College
Institution
1
1 / 3

Data updated 12 August 2026

Share

Share

Share